FDA Expands Approval of Imaging Agent Cytalux for Lung Cancer ...Middle East

Medscape - News
The expanded indication for pafolacianine (Cytalux) follows an initial approval in November 2021 for use in patients with ovarian cancer. Medscape Medical News

Hence then, the article about fda expands approval of imaging agent cytalux for lung cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Expands Approval of Imaging Agent Cytalux for Lung Cancer )

Apple Storegoogle play

Last updated :

Also on site :



Latest News